ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

Clinical Center’s Cancer Nursing Recruitment Improved

January 10, 1986

NCI director says rules hurt retention, recruitment, cites Liotta’s departure.

April 8, 2005

NCAB Accepts Report, Seeks Comment From Researchers, Patient Groups

May 19, 1995

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002